Otello Stampacchia's most recent trade in Ikena Oncology Inc was a trade of 17,520 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 7, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ikena Oncology Inc | Otello Stampacchia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 17,520 | 17,520 | - | - | Stock Option (Right to Buy) | |
| Ikena Oncology Inc | Otello Stampacchia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 17,520 | 17,520 | - | - | Stock Option (Right to Buy) | |
| Kronos Bio Inc | Otello Stampacchia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 34,000 | 34,000 | - | - | Stock Option (Right to Buy) | |
| Ikena Oncology Inc | Otello Stampacchia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 13,419 | 13,419 | - | - | Stock Option (Right to Buy) | |
| Ikena Oncology Inc | Otello Stampacchia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2021 | 13,419 | 13,419 | - | - | Stock Option (Right to Buy) | |
| Kronos Bio Inc | Otello Stampacchia | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 20,600 | 20,600 | - | - | Stock Option (Right to Buy) | |
| Ikena Oncology Inc | Otello Stampacchia | Director | 30 Mar 2021 | 12,870,933 | 0 | - | - | Series B Preferred Stock | ||
| Ikena Oncology Inc | Otello Stampacchia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2021 | 12,870,933 | 12,870,933 | - | - | Series B Preferred Stock | |
| Ikena Oncology Inc | Otello Stampacchia | Director | 30 Mar 2021 | 1,799,123 | 1,799,123 | - | - | Common Stock | ||
| Ikena Oncology Inc | Otello Stampacchia | Director | Grant, award, or other acquisition of securities at price $ 16.00 per share. | 30 Mar 2021 | 450,000 | 2,249,123 | - | 16 | 7,200,000 | Common Stock |
| Kronos Bio Inc | Otello Stampacchia | Director, Ten Percent Owner | 14 Oct 2020 | 1,606,220 | 1,625,671 | - | - | Common Stock | ||
| Kronos Bio Inc | Otello Stampacchia | Director, Ten Percent Owner | 14 Oct 2020 | 1,522,484 | 0 | - | - | Series Seed Preferred Stock | ||
| Kronos Bio Inc | Otello Stampacchia | Director, Ten Percent Owner | 14 Oct 2020 | 1,376,313 | 3,001,984 | - | - | Common Stock | ||
| Kronos Bio Inc | Otello Stampacchia | Director, Ten Percent Owner | 14 Oct 2020 | 1,304,563 | 0 | - | - | Series A Preferred Stock | ||
| Kronos Bio Inc | Otello Stampacchia | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 14 Oct 2020 | 450,000 | 3,818,283 | - | 19 | 8,550,000 | Common Stock |
| Kronos Bio Inc | Otello Stampacchia | Director, Ten Percent Owner | 14 Oct 2020 | 366,299 | 3,368,283 | - | 16.2 | 5,915,729 | Common Stock |